Shingles immunisation programme [Shingrix庐]: evaluation reports

Research and analysis

Shingles immunisation programme [Shingrix庐]: evaluation reports

Evaluation of the Shingrix庐 herpes zoster (shingles) vaccination programme in England: academic year 2023 to 2024.

From:: UK Health Security Agency
Published: 29 August 2024
Last updated: 30 January 2025 鈥� See all updates

Applies to England

Documents

Shingrix庐 vaccine uptake report (adults eligible from September 2023 to August 2024 and vaccinated to the end of October 2024): England

Ref: HPR 19(1)

HTML

Shingrix庐 vaccine uptake report (adults eligible from September 2023 to May 2024 and vaccinated to the end of July 2024): England

Ref: HPR 18(8)

HTML

Ref: HPR 18(8)

MS Excel Spreadsheet, 89.6 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingrix庐 vaccine uptake report (adults eligible from September 2023 to February 2024 and vaccinated to the end of April 2024): England

Ref: HPR 18(7)

HTML

Ref: HPR 18(7)

MS Excel Spreadsheet, 118 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

Details

For reports covering earlier years, when Zostavax庐 was in use, see聽Herpes zoster (shingles) immunisation programme 2023 to 2024: evaluation reports.

Published 29 August 2024

Last updated 30 January 2025 show all updates

30 January 2025
Added quarterly report for Q3 of epidemiological year 2023/24.
26 September 2024
Added quarterly report and data file for Q2 of epidemiological year 2023/24.
29 August 2024
First published.

188体育